Coffee and tea consumption and the risk of Parkinson's disease

被引:184
作者
Hu, Gang
Bidel, Siamak
Jousilahti, Pekka
Antikainen, Riitta
Tuomilehto, Jaakko
机构
[1] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, FIN-00300 Helsinki, Finland
[2] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
[3] Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland
[4] Univ Oulu, Oulu City Hosp, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland
[5] S Ostrobothnia Cent Hosp, Seinajoki, Finland
关键词
coffee; Parkinson's disease; tea;
D O I
10.1002/mds.21706
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Several prospective studies have assessed the association between coffee consumption and Parkinson's disease (PD) risk, but the results are inconsistent. We examined the association of coffee and tea consumption with the risk of incident PD among 29,335 Finnish subjects aged 25 to 74 years without a history of PD at baseline. During a mean follow-up of 12.9 years, 102 men and 98 women developed an incident PD. The multivariate-adjusted (age, body mass index, systolic blood pressure, total cholesterol, education, leisure-time physical activity, smoking, alcohol and tea consumption, and history of diabetes) hazard ratios (HRs) of PD associated with the amount of coffee consumed daily (0, 1-4, and >= 5 cups) were 1.00, 0.55, and 0.41 (P for trend = 0.063) in men, 1.00, 0.50, and 0.39 (P for trend = 0.073) in women, and 1.00, 0.53, and 0.40 (P for trend = 0.005) in men and women combined (adjusted also for sex), respectively. In both sexes combined, the multivariate-adjusted HRs of PD for subjects drinking >= 3 cups of tea daily compared with tea nondrinkers was 0.41 (95% CI 0.20-0.83). These results suggest that coffee drinking is associated with a lower risk of PD. More tea drinking is associated with a lower risk of PD. (c) 2007 Movement Disorder Society.
引用
收藏
页码:2242 / 2248
页数:7
相关论文
共 40 条
[1]   Coffee consumption, gender, and Parkinson's disease mortality in the Cancer Prevention Study II cohort: The modifying effects of estrogen [J].
Ascherio, A ;
Weisskopf, MG ;
O'Reilly, EJ ;
McCullough, ML ;
Calle, EE ;
Rodriguez, C ;
Thun, MJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (10) :977-984
[2]   Caffeine, postmenopausal estrogen, and risk of Parkinson's disease [J].
Ascherio, A ;
Chen, H ;
Schwarzschild, MA ;
Zhang, SM ;
Colditz, GA ;
Speizer, FE .
NEUROLOGY, 2003, 60 (05) :790-795
[3]   Prospective study of caffeine consumption and risk of Parkinson's disease in men and women [J].
Ascherio, A ;
Zhang, SMM ;
Hernán, MA ;
Kawachi, I ;
Colditz, GA ;
Speizer, FE ;
Willett, WC .
ANNALS OF NEUROLOGY, 2001, 50 (01) :56-63
[4]   Protective effect of enalapril on vascular reactivity of the rat aorta [J].
Baluchnejadmojarad, T ;
Roghani, M ;
Imani, A .
VASCULAR PHARMACOLOGY, 2004, 40 (06) :301-307
[5]   Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes [J].
Bidel, S. ;
Hu, G. ;
Qiao, Q. ;
Jousilahti, P. ;
Antikainen, R. ;
Tuomilehto, J. .
DIABETOLOGIA, 2006, 49 (11) :2618-2626
[6]   Neuroprotection in the MPTP parkinsonian C57BL/6 mouse model by a compound isolated from tobacco [J].
Castagnoli, KP ;
Steyn, SJ ;
Petzer, JP ;
Van der Schyf, CJ ;
Castagnoli, N .
CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (05) :523-527
[7]   Weight loss in Parkinson's disease [J].
Chen, HL ;
Zhang, SMM ;
Hernán, MA ;
Willett, WC ;
Ascherio, A .
ANNALS OF NEUROLOGY, 2003, 53 (05) :676-679
[8]   Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease [J].
Chen, JF ;
Xu, K ;
Petzer, JP ;
Staal, R ;
Xu, YH ;
Beilstein, M ;
Sonsalla, PK ;
Castagnoli, K ;
Castagnoli, N ;
Schwarzschild, MA .
JOURNAL OF NEUROSCIENCE, 2001, 21 (10) :art. no.-RC143
[9]   METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE [J].
CHIBA, K ;
TREVOR, A ;
CASTAGNOLI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) :574-578
[10]  
COX DR, 1972, J R STAT SOC B, V34, P187